192 related articles for article (PubMed ID: 19120877)
1. Using a surveillance system to identify and treat newly acquired hepatitis C infection.
Walsh N; Lim M; Hellard M
J Gastroenterol Hepatol; 2008 Dec; 23(12):1891-4. PubMed ID: 19120877
[TBL] [Abstract][Full Text] [Related]
2. Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.
Wiegand J
J Gastroenterol Hepatol; 2008 Dec; 23(12):1782-4. PubMed ID: 19120870
[No Abstract] [Full Text] [Related]
3. Acute hepatitis C: prevention and treatment.
Ozaras R; Tahan V
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
[TBL] [Abstract][Full Text] [Related]
4. [Acute hepatitis C: a retrospective study of 62 cases].
Morin T; Pariente A
Gastroenterol Clin Biol; 2002 Nov; 26(11):994-1000. PubMed ID: 12483131
[TBL] [Abstract][Full Text] [Related]
5. Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications.
Guy R; Devadason D; Lim M; Higgins N; Pedrana A; Gibson K; Lewis J; Spelman T; White B; Kaldor J; Hellard M
Commun Dis Intell Q Rep; 2008 Jun; 32(2):250-6. PubMed ID: 18767425
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C in state correctional facilities.
Spaulding A; Greene C; Davidson K; Schneidermann M; Rich J
Prev Med; 1999 Jan; 28(1):92-100. PubMed ID: 9973592
[TBL] [Abstract][Full Text] [Related]
7. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
Hopwood M; Treloar C
Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
[TBL] [Abstract][Full Text] [Related]
8. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
Hagan H; Latka MH; Campbell JV; Golub ET; Garfein RS; Thomas DA; Kapadia F; Strathdee SA;
Clin Infect Dis; 2006 Mar; 42(5):669-72. PubMed ID: 16447112
[TBL] [Abstract][Full Text] [Related]
9. Acute hepatitis C: current status and remaining challenges.
Santantonio T; Wiegand J; Gerlach JT
J Hepatol; 2008 Oct; 49(4):625-33. PubMed ID: 18706735
[TBL] [Abstract][Full Text] [Related]
10. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.
Deterding K; Wiegand J; Grüner N; Hahn A; Jäckel E; Jung MC; Buggisch P; Galle P; Berg T; Hinrichsen H; Potthoff A; Zeuzem S; Cornberg M; Manns M; Wedemeyer H
Z Gastroenterol; 2009 Jun; 47(6):531-40. PubMed ID: 19533544
[TBL] [Abstract][Full Text] [Related]
11. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C treatment for injection drug users: a review of the available evidence.
Hellard M; Sacks-Davis R; Gold J
Clin Infect Dis; 2009 Aug; 49(4):561-73. PubMed ID: 19589081
[TBL] [Abstract][Full Text] [Related]
13. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.
Wu HX; Wu J; Wong T; Donaldson T; Dinner K; Andonov A; Ip Chan J; Moffat B; Baptiste B; Furseth J; Poliquin D; Bolesnikov G; Giulivi A; Paton S
Scand J Infect Dis; 2006; 38(6-7):482-9. PubMed ID: 16798699
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
Gidding HF; Topp L; Middleton M; Robinson K; Hellard M; McCaughan G; Maher L; Kaldor JM; Dore GJ; Law MG
J Gastroenterol Hepatol; 2009 Oct; 24(10):1648-54. PubMed ID: 19798783
[TBL] [Abstract][Full Text] [Related]
15. Improving surveillance for acute hepatitis C.
Deacon RM; Wand H; Stelzer-Braid S; Treloar C; Maher L
Commun Dis Intell Q Rep; 2011 Mar; 35(1):16-20. PubMed ID: 21698979
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C enhanced surveillance: results from a southeastern Sydney pilot program.
Bateman-Steel CR; Smedley EJ; Kong M; Ferson MJ
Public Health Res Pract; 2015 Mar; 25(2):e2521520. PubMed ID: 25848738
[TBL] [Abstract][Full Text] [Related]
17. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006.
Williams IT; Bell BP; Kuhnert W; Alter MJ
Arch Intern Med; 2011 Feb; 171(3):242-8. PubMed ID: 21325115
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
[TBL] [Abstract][Full Text] [Related]
19. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area.
Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A
Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557
[TBL] [Abstract][Full Text] [Related]
20. Receiving a hepatitis C-positive diagnosis.
Hopwood M; Treloar C
Intern Med J; 2004; 34(9-10):526-31. PubMed ID: 15482264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
